22157.jpg
Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities
April 24, 2024 04:13 ET | Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Global Market Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2023-2030" report has been added to ...
Straits Research Pvt Ltd
Drug Discovery Informatics Market Size is expected to reach USD 7.44 billion by 2031, growing at a CAGR of 10.8%: Straits Research
March 18, 2024 09:30 ET | Straits Research Private Limited
New York, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Drug discovery informatics continues to revolutionize the field of drug discovery by leveraging cutting-edge technologies and...
22157.jpg
Therapeutic Drug Monitoring Market Experiencing Robust Growth, Bolstered by Advanced Healthcare IT Integration - Global Trends, Opportunity, and Forecast, 2018-2028F
February 08, 2024 09:33 ET | Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Biosimulation Market
Global Biosimulation Market to Surge, Predicted CAGR of 16.98% from 2024 to 2034, Driven by Pharmaceutical R&D and Technological Advancements
January 29, 2024 10:53 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
22157.jpg
United States Zuranolone (SAGE-217) Emerging Drug Insights and Market Forecasts, 2019-2022 and 2023-2032
December 15, 2023 08:53 ET | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "United States SAGE-217 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report...
Global Pharmacokinetics Services Market
Pharmacokinetics Services Market Report 2023: A Global $1.75+ Billion Industry by 2030 - Analysis by Drug Type (Small Molecules) & End-use (Biotechnology & Pharmaceutical Companies)
November 14, 2023 03:13 ET | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use...
Qualigen-Logo-Tag.png
Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
August 15, 2023 08:30 ET | Qualigen Therapeutics, Inc.
Investigational New Drug (IND) clearance transitions Qualigen from preclinical to clinical-stage company Company divests FastPack® diagnostics business for approximately $5 million in all cash...
Global Drug Discovery Informatics Market
Global Drug Discovery Informatics Market to Reach $6.01 Billion by 2027, Driven by Technological Advancements and Increasing Prevalence of Chronic Diseases
July 21, 2023 05:48 ET | Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This comprehensive report provides...
Global Therapeutic Drug Monitoring Market
Global Therapeutic Drug Monitoring Market Report 2023: Rising Adoption of Precision Medicine Drives Growth
May 03, 2023 09:23 ET | Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market by Product, Technology, Drug Class, End-users: Global Opportunity Analysis and Industry Forecast, 2021-2031" report...
Immuneering-logo (1).png
Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline
April 18, 2023 09:00 ET | Immuneering Corporation
Data presented at AACR Annual Meeting support IMM-1-104's potential to address a broad population of patients with RAS mutant tumorsIMM-1-104 well tolerated with no dose limiting toxicities (DLTs) or...